Development and challenges of antimicrobial peptides for therapeutic applications
More than 3000 antimicrobial peptides (AMPs) have been discovered, seven of which have been approved by the U.S. Food and Drug Administration (FDA). Now commercialized, these seven peptides have mostly been utilized for topical medications, though some have been injected into the body to treat sever...
Main Authors: | Chen, Charles H. (Author), Lu, Timothy K (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Research Laboratory of Electronics (Contributor), Broad Institute of MIT and Harvard (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor) |
Format: | Article |
Language: | English |
Published: |
Multidisciplinary Digital Publishing Institute,
2020-05-28T16:02:53Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
by: Charles H. Chen, et al.
Published: (2020-01-01) -
Antimicrobial Peptides for Therapeutic Applications: A Review
by: Tsogbadrakh Mishig-Ochir, et al.
Published: (2012-10-01) -
Antimicrobial Peptides as Therapeutic Agents
by: Mathew Upton, et al.
Published: (2012-01-01) -
Insect Cecropins, Antimicrobial Peptides with Potential Therapeutic Applications
by: Daniel Brady, et al.
Published: (2019-11-01) -
Antimicrobial Dendrimeric Peptides: Structure, Activity and New Therapeutic Applications
by: Mariano A. Scorciapino, et al.
Published: (2017-03-01)